Josje Otten

Two‐year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months

Rik Johannes Leonardus van der Lans, Josje Otten, Gwijde Flavius Jacobus Petrus Maria Adriaensen et al. · Allergy · 2023 · 64 citations · Full text

Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision making

Josje Otten, Rik Johannes Leonardus van der Lans, Eugenio De Corso et al. · Expert Review of Clinical Immunology · 2023 · 27 citations

Real-world effectiveness of dupilumab in a European cohort of chronic rhinosinusitis with nasal polyps (CHRINOSOR)

Sven Seys, Sven Schneider, Joost de Kinderen et al. · Journal of Allergy and Clinical Immunology · 2024 · 18 citations · Full text

Hypereosinophilia during dupilumab treatment in patients with chronic rhinosinusitis with nasal polyps

Paul R. Kemp, Rik Johannes Leonardus van der Lans, Josje Otten et al. · Rhinology Journal · 2023 · 16 citations